Over the years our sponsor, Kazan Law, has built philanthropic relationships with mesothelioma clients to help fund mesothelioma research and new mesothelioma technology. One such example is mesothelioma victim Gordon Bankhead and his wife, Emily, who wanted to give back and do more for future generations of asbestos victims. As a result of Kazan Law’s supportive relationship with UCSF’s Thoracic Oncology Program, the Bankhead family generously donated $100,000 from their jury verdict award towards the purchase of a $750,000 machine that utilizes innovative new technology for mesothelioma … [Read more...]
Mesothelioma Research
Kazan Law Funds University of California, San Francisco Mesothelioma Research
Our mesothelioma law firm’s charitable foundation, the Kazan McClain Partners’ Foundation, has partnered with and donated more than $20 million in grant monies to community, health, and civic organizations. One of our foundation’s most collaborative partners is the University of California, San Francisco (UCSF), a world renowned cancer research institution and the top public recipient of National Institutes of Health (NIH) research funding for the 6th consecutive year in 2017. In 2014, our foundation provided a large donation to UCSF cancer researchers seeking to understand mesothelioma cancer … [Read more...]
Kazan Law’s Tradition of Funding Mesothelioma Research
Mesothelioma Circle’s sponsor, Kazan, McClain, Satterley & Greenwood, has been a pioneering force in asbestos litigation since 1974. The firm’s charitable foundation, the Kazan McClain Partners’ Foundation, formed in 1994, has pledged their serious and substantial commitment to giving back by donating more than $20 million in grant monies to community, health, and civic organizations. A sizable portion of this commitment has gone to funding mesothelioma research in the hopes of accelerating the process of finding new breakthroughs in the fight against this life-threatening disease. Keeping … [Read more...]
Blood Platelet Mesothelioma Research Tied to Survival Rate
Mesothelioma research from the University of Maryland School of Medicine in Baltimore has revealed an important factor affecting survival rates for peritoneal mesothelioma. The study set out to refine the way patients are selected for a certain peritoneal mesothelioma treatment regimen that has been shown to prolong survival. As with any new mesothelioma research study, careful testing and monitoring plays a huge part in extrapolating data and measuring positive results. Peritoneal Mesothelioma Mesothelioma is a cancer caused by exposure to asbestos. The mesothelium is the lining that protects … [Read more...]
Study Could Help Mesothelioma Cognitive Impairment
Because mesothelioma can take several decades to manifest, many of the people diagnosed with this asbestos-caused cancer are seniors. While mesothelioma surgery can help patients of all ages, older patients are more likely to suffer from mesothelioma cognitive impairment after surgery than younger ones. The phenomenon of post-surgical mesothelioma cognitive impairment, especially in older patients, has been known for years, but doctors have not been able to determine exactly what causes it and how to treat it. Some studies show links between mesothelioma cognitive impairment and the length of … [Read more...]
New Device Detects Asbestos Fibers in Mesothelioma Patients
A new device being tested in Canada may hold out hope for future mesothelioma patients of catching mesothelioma at an earlier stage. Earlier detection of the presence of asbestos fibers could possibly improve treatment outcomes and prolong the lives of mesothelioma patients. How an Earlier Diagnostic Tool Holds Promise for Mesothelioma Patients For each mesothelioma patient, receiving a dreaded mesothelioma diagnosis plays a major role in the tragedy of mesothelioma. Not only because it indicates the presence of this lethal illness but because the diagnosis mostly comes too late. Decades … [Read more...]
New Surgery Prolongs Survival Rates for Mesothelioma Patients
New hope for mesothelioma patients: those are welcome words. Even better, a study published in the Annals of Thoracic Surgery in 2016 offers hope of longer survival times for patients with advanced pleural mesothelioma. The study found that a combination of pleurectomy-decortication surgery and other treatments significantly increased survival for mesothelioma patients with the epithelial pleural form of the disease. What is Epithelial Pleural Mesothelioma? Mesothelioma is a rare cancer of the linings around organs. Malignant mesothelioma tumors develop when tiny, asbestos fibers lodge in the … [Read more...]
Mesothelioma Research Uncovers Possible New Treatment
Mesothelioma research continues to astonish even those of us who have been tracking mesothelioma research progress for a long time. Just when you may despair and feel that nothing new about this lethal illness has emerged in a long time, along comes an amazing new finding. Mesothelioma Circle is pleased to present you with this hopeful piece of mesothelioma research news. Mesothelioma Research Shows Tumors Create Their Own Blood Vessels This new mesothelioma research comes from Australia, a country with one of the world’s highest rates of mesothelioma. Researchers at Australia’s Flinders … [Read more...]
Mesothelioma Research and Big Data
One of the most promising cutting edge areas of mesothelioma research is happening in cyberspace. Researchers are combining new and better techniques for decoding the genetic makeup of each patient’s tumor with big data to tailor custom treatments and improve outcomes and survival. What is Big Data? If you’re not a computer geek (and most of us are not), the concept of big data can be hard to get your head around. Big data refers to sets of information that are so enormous they can’t be analyzed by a regular computer or computer program. As scientists have gotten better and better at … [Read more...]
iMig 2016 Young Investigator Awards Winner Marissa Williams
https://youtu.be/El5ldDC0GSM Our sincere congratulations go to talented Marissa Williams who was named one of the five winners of the International Mesothelioma Interest Group 2016, iMig 2016, Young Investigator Awards. Currently, Ms. Williams is earning a PhD at the Asbestos Diseases Research Institute in Australia. iMig 2016 Mesothelioma Research Ms. Williams research has determined that the PD-L1 protein is an adverse prognostic indicator of pleural mesothelioma and is associated with low microRNA levels. Williams also found that by re-expressing these microRNAs, the PD-L1 expression was … [Read more...]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »